Innovative medical treatments and cures created right here in New Jersey help millions of Patients lead longer, healthier lives. Now, New Jersey’s innovative life sciences companies are working tirelessly to develop treatments and innovations to help stop the COVID-19 pandemic. But Patients and medical innovation itself may be under threat from organizations that use questionable, one-size-fits-all methods to determine drug value and access.

As part of our ongoing Business UnUsual Webinar Series, BioNJ is convening knowledgeable experts in the health care research and Patient advocacy space for an educational webinar on the value of medical innovation during and beyond COVID-19 and the importance of protecting Patients and innovation from ICER and other one-size-fits-all value frameworks. Come ready to ask questions!